Home - India - Rediff - China grants conditional nod to homegrown vaccine

China grants conditional nod to homegrown vaccine


31 December 2020 11:22

The approval comes a day after Sinopharm said its vaccine showed 79.34 per cent efficacy and a 99.52 per cent antibody-positive conversion rate in the interim results of the Phase III clinical trials..
China grants conditional nod to homegrown vaccine. This article is published at 31 December 2020 11:22 from Rediff India News and Top Stories, click on the read full article link below to see further details.


Read Full Article on Rediff >>

Tags : China, grants, conditional, homegrown, vaccine